Clinical Study
IgG4-Related Perineural Disease
Table 1
Clinical characteristics, laboratory data, and initial dose of steroid.
| Case | Age | Gender | Symptom | IgG (mg/dL)* | IgG4 (mg/dL)† | ANA (titer) | IgE (IU/mL)‡ | Initial dose of steroid |
| 1 | 55 | Male | Double vision, subcutaneous nodule in cheek | 4845 | 2050 | ×40 | 988 | 30 mg/day | 2 | 53 | Male | Left proptosis, double vision | NA | 372 | ×40 | NA | 30 mg/day | 3 | 61 | Male | Lacrimal gland enlargement | 1450 | 463 | <40 | 4608 | 20 mg/day | 4 | 44 | Male | Right proptosis, double vision, lacrimal gland enlargement | 1146 | 325 | <40 | 151 | 30 mg/day | 5 | 58 | Male | Epigastralgia | 2850 | 1280 | NA | NA | 30 mg/day | 6 | 74 | Male | Lacrimal gland enlargement, cervical lymph node enlargement | 6024 | 2550 | NA | NA | 30 mg/day | 7 | 61 | Male | Palpable left cervical mass, lacrimal gland enlargement, | 7364 | 3440 | ×2560 | 1146 | 40 mg/day |
|
|
NA: not analyzed; *normal range < 1600 mg/dL; †normal range < 135 mg/dL; ‡normal range < 170 IU/mL.
|